HGS: LymphoStat-B For Lupus Not Like Failed Rituxan
This article was originally published in The Pink Sheet Daily
Executive Summary
Analysts cautiously optimistic the antibody candidate will succeed.
You may also be interested in...
HGS’ Lupus Candidate Demonstrates Efficacy In Three-Year Continuation Study
The biotech continues to aim for a 2010 BLA for LymphoStat-B, with Phase III data expected next year.
HGS’ Lupus Candidate Demonstrates Efficacy In Three-Year Continuation Study
The biotech continues to aim for a 2010 BLA for LymphoStat-B, with Phase III data expected next year.
HGS Invests In Oncology As Phase III Drugs Near Submission
Human Genome Sciences targets 2010 for Albuferon and LymphoStat-B launches.